A novel approach to pharmacodynamic assessment of antimicrobial agents: new insights to dosing regimen design
about
Novel modeling framework to guide design of optimal dosing strategies for β-lactamase inhibitors.Pharmacokinetics and pharmacodynamics of continuous-infusion meropenem in pediatric hematopoietic stem cell transplant patientsDosing nomograms for attaining optimum concentrations of meropenem by continuous infusion in critically ill patients with severe gram-negative infections: a pharmacokinetics/pharmacodynamics-based approachPharmacological considerations for the proper clinical use of aminoglycosides.Pharmacokinetic/pharmacodynamic (PK/PD) indices of antibiotics predicted by a semimechanistic PKPD model: a step toward model-based dose optimization.Immediate outcomes of bacterial meningitis in childhood may benefit from slow initial β-lactam infusion and oral paracetamol.Relationship between pharmacodynamic indices and killing patterns in vitro.Determining β-lactam exposure threshold to suppress resistance development in Gram-negative bacteria.Pharmacokinetics and pharmacodynamics of continuous infusion meropenem in overweight, obese, and morbidly obese patients with stable and unstable kidney function: a step toward dose optimization for the treatment of severe gram-negative bacterial inAntimicrobial drug discovery.Exploring the Pharmacokinetic/Pharmacodynamic Relationship of Relebactam (MK-7655) in Combination with Imipenem in a Hollow-Fiber Infection Model.
P2860
Q35941209-B444A2BB-881F-4D09-996B-9BB1A0159339Q35960828-1EBFC440-5EA2-4FBC-85FA-9683747608C6Q36396195-57A3B32F-B8D5-42D1-ADAA-E64CD13EC071Q37956403-A28B76E1-8FA1-45B0-A214-39E28B1F7026Q38626980-1DFA8CCE-4E67-4DFF-88D2-3AB434406A7EQ39696732-A15EB7A3-5706-46F4-98A6-051DA2F00657Q39735382-0AA98855-F434-4FEC-B348-CCB1D88E94DCQ40346786-1CAC39CB-0E25-4F00-9BBC-2328B4319EC0Q41349399-10F33024-6DA1-4F38-BE51-98B6BCC89E00Q44519233-32AD3E44-D414-4E2D-8B86-EFFD48538A8BQ52366733-6E28A7DA-2868-46F1-916D-6D9EAD1C83D5
P2860
A novel approach to pharmacodynamic assessment of antimicrobial agents: new insights to dosing regimen design
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A novel approach to pharmacody ...... ights to dosing regimen design
@ast
A novel approach to pharmacody ...... ights to dosing regimen design
@en
A novel approach to pharmacody ...... ights to dosing regimen design
@nl
type
label
A novel approach to pharmacody ...... ights to dosing regimen design
@ast
A novel approach to pharmacody ...... ights to dosing regimen design
@en
A novel approach to pharmacody ...... ights to dosing regimen design
@nl
prefLabel
A novel approach to pharmacody ...... ights to dosing regimen design
@ast
A novel approach to pharmacody ...... ights to dosing regimen design
@en
A novel approach to pharmacody ...... ights to dosing regimen design
@nl
P2860
P1476
A novel approach to pharmacody ...... ights to dosing regimen design
@en
P2093
Michael Nikolaou
Vincent H Tam
P2860
P304
P356
10.1371/JOURNAL.PCBI.1001043
P407
P577
2011-01-06T00:00:00Z